Jake Beverage

Jake Beverage, PharmD is a Co-founder at Sirenas, overseeing business development and strategic alliance activities. Dr. Beverage has over 16 years of experience in the pharmaceutical industry in roles spanning discovery, development and commercialization. He has served as Chief Operating Officer and interim Chief Executive Officer at Sirenas since its founding in 2012. Prior to Sirenas, he held roles of increasing responsibility at Genentech, serving as a director in the medical affairs group for products including Herceptin™, Avastin™, Tarceva™ and Xeloda™, and in sales and marketing roles within the commercial division. Before Genentech, Dr. Beverage served on clinical development teams spanning Phases I-IV at Chugai Pharma USA and Corixa Corporation, with a focus on oncology therapeutics. Dr. Beverage received his doctor of pharmacy from the University of California, San Francisco and earned a bachelor’s degree in biology from Vanderbilt University.